Back to LYEL
BlackRock, Inc. LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
27
Latest value
$323K
Q3 2026
Peak value
$5.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $19K |
| Q4 2025 | $18K |
| Q4 2025 | $1.6M |
| Q4 2025 | $3.5M |
| Q4 2025 | $419K |
| Q4 2025 | $339 |
| Q1 2026 | $83K |
| Q1 2026 | $12K |
| Q1 2026 | $1.1M |
| Q1 2026 | $2.3M |
| Q1 2026 | $319K |
| Q1 2026 | $17K |
| Q2 2026 | $111K |
| Q2 2026 | $405K |
| Q2 2026 | $310K |
| Q2 2026 | $5.7M |
| Q2 2026 | $3.1M |
| Q2 2026 | $531K |
| Q2 2026 | $3K |
| Q3 2026 | $227K |
| Q3 2026 | $282K |
| Q3 2026 | $245K |
| Q3 2026 | $3.9M |
| Q3 2026 | $2.5M |
| Q3 2026 | $6K |
| Q3 2026 | $418K |
| Q3 2026 | $323K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $323K | 33.0K | — | — |
| Q3 2026 | $418K | 42.7K | — | — |
| Q3 2026 | $6K | 624 | — | — |
| Q3 2026 | $2.5M | 250.9K | — | — |
| Q3 2026 | $3.9M | 394.9K | — | — |
| Q3 2026 | $245K | 25.0K | — | — |
| Q3 2026 | $282K | 28.8K | — | — |
| Q3 2026 | $227K | 23.2K | — | — |
| Q2 2026 | $3K | 213 | — | — |
| Q2 2026 | $531K | 37.8K | — | — |
| Q2 2026 | $3.1M | 223.5K | — | — |
| Q2 2026 | $5.7M | 404.0K | — | — |
| Q2 2026 | $310K | 22.1K | — | — |
| Q2 2026 | $405K | 28.9K | — | — |
| Q2 2026 | $111K | 7.9K | — | — |
| Q1 2026 | $17K | 848 | — | — |
| Q1 2026 | $319K | 15.9K | — | — |
| Q1 2026 | $2.3M | 115.2K | — | — |
| Q1 2026 | $1.1M | 55.1K | — | — |
| Q1 2026 | $12K | 592 | — | — |
| Q1 2026 | $83K | 4.2K | — | — |
| Q4 2025 | $339 | 11 | — | — |
| Q4 2025 | $419K | 13.6K | — | — |
| Q4 2025 | $3.5M | 115.1K | — | — |
| Q4 2025 | $1.6M | 51.9K | — | — |
| Q4 2025 | $18K | 592 | — | — |
| Q4 2025 | $19K | 610 | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M